The dawn of in vivo immune cell engineering in oncology

June, CH, O’Connor, RS, Kawalekar, OU, Ghassemi, S. and Milone, MC Science 3591361-1365 (2018).
Müller, F. et al. N.Engl. J.Med. 390687-700 (2024).
Mikhael, J., Fowler, J. and Shah, N. JCO Oncol. Practice. 18800-807 (2022).
Morris, EC, Neelapu, SS, Giavridis, T. and Sadelain, M. Nat. Reverend Immunol. 2285-96 (2022).
Ottaviano, G. and Qasim, W. Leukemia 391325-1333 (2025).
Uslu, U. and June, CH Nat. Biotechnology. 43506-515 (2025).
Escobar, G., Berger, TR and Maus, MV Cell Rep. Med. https://doi.org/10.1016/j.xcrm.2025.102353 (2025).
Diorio, C., Teachey, DT and Grupp, SA Nat. Reverend Clin. Oncol. 2210-27 (2025).
Bot, A. et al. Nat Rev. https://doi.org/10.1038/s41573-025-01291-5 (2025).
Xu, J. et al. Lancet 406228-231 (2025).
Wang, Q. et al. N.Engl. J.Med. 3931542-1544 (2025).
Nicolai, CJ et al. Blood 144977-987 (2024).
Hunter, TL et al. Science 3881311-1317 (2025).
Andorko, JI et al. Mol. There. 334937-4952 (2025).
Kantarjian, H. et al. N.Engl. J.Med. 376836-847 (2017).
Onuora, S. Nat. Reverend Rheumatol. 20667 (2024).
Philipp, N. et al. Blood 1401104-1118 (2022).
Urits, I. et al. Neurol. There. 9301-315 (2020).
Chen, DS and Mellman, I. Immunity 391–10 (2013).
Nagarsheth, New Brunswick et al. Nat. Med. 27419-425 (2021).
Cheloni, G. et al. Nat. Common. 164819 (2025).
Scholler, N. et al. Nat. Med. 281872-1882 (2022).
Chen, P.-H. et al. JCI Overview 5e134612 (2020).
Locke, FL et al. Blood Adv. 44898-4911 (2020).
Bot, A., Dudley, M., Shelley, D. and Sotiropoulou, PA Nat. Rev. https://doi.org/10.1038/d41573-025-00191-y (2025).




